News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2023-01-14 4:26:59 pm (SPAC) Special Purpose Acquisition Investigation: SMFR, SFT, SKIL, SMRT, Contact Shareholder Rights Law Firm Johnson Fistel GlobeNewsWire
2023-01-09 5:30:0 am Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance GlobeNewswire
2022-12-30 5:30:0 am Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference GlobeNewswire
2022-12-05 5:0:0 am New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU GlobeNewswire
2022-11-14 5:2:0 am Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction GlobeNewswire
2022-11-04 1:5:0 pm Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022 GlobeNewswire
2022-10-31 6:0:0 am Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies GlobeNewswire
2022-10-27 5:0:0 am Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns GlobeNewswire
2022-10-26 5:0:0 am Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information